Trade Moderna Inc ^MRNA

FDA Expands RSV Vaccine Approval to At-Risk Adults | Newsmax.com

Tobam Boosts Stock Position in Moderna, Inc. (NASDAQ:MRNA)

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Union Bancaire Privee UBP SA

FDA Approves Moderna's RSV Vaccine for Younger Adults (1)

Health: US FDA approves expanded use of Moderna's RSV vaccine for at-risk adults

Coronavirus - Articles | BioWorld

FDA Approves Moderna's RSV Vaccine, MRESVIA, For Younger Adults

Moderna Insiders Added US$6.01m Of Stock To Their Holdings

Moderna Seeks Outside Investors to Fund Select Vaccine Trials

To Outrun the Complacent Class

GAMMA Investing LLC Boosts Holdings in Moderna, Inc. (NASDAQ:MRNA)

​​Buying hype doesn't work - the case of Moderna​ | IG South Africa

​​Buying hype doesn't work - the case of Moderna​ | IG International

​​Buying hype doesn't work - the case of Moderna​ - IG UK

TB Alternative Assets Ltd. Acquires Shares of 652,373 Moderna, Inc. (NASDAQ:MRNA)

Rhumbline Advisers Grows Stock Holdings in Moderna, Inc. (NASDAQ:MRNA)

Analysts' Opinions Are Mixed on These Healthcare Stocks: Quince Therapeutics (QNCX) and Moderna (MRNA) | Markets Insider

COVID-19 Vaccine Reform Is Moving Slower Than Many Had Hoped | ZeroHedge

In axing mRNA contract, Trump delivers another blow to US biosecurity, former officials say

What is driving a surge in COVID cases in India, other countries? | Coronavirus pandemic News | Al Jazeera

How Is Moderna's Stock Performance Compared to Other Biotechnology Stocks?

Moderna, Inc. (NASDAQ:MRNA) Given Average Recommendation of "Hold" by Brokerages

With Pseudoscience Reigning, Debunker Offers Tips For Fighting Back 06/05/2025

FDA Not Recommending Newly Approved COVID-19 Vaccine: Official | ZeroHedge

Case: Patents/Claim Construction (Fed. Cir.)

US appeals court sides with Moderna on COVID patent claims

Fed Circ upholds Moderna's COVID-19 vaccine win against Alnylam

Alnylam Fails to Revive Patent Infringement Suit Against Moderna

Pharma execs speak out: UK pricing rebates scare investors | BioWorld

Alpha Wealth Funds LLC Buys Shares of 15,000 Moderna, Inc. (NASDAQ:MRNA)

US Fed Circuit rules in favor of Moderna in patent squabble | BioWorld

HHS axes $776 million Moderna bird flu vaccine deal over safety, ethical concerns - NaturalNews.com

Moderna Will Test New Covid Shot Against Placebo, RFK Says (1)

Moderna's (MRNA) "Market Perform" Rating Reaffirmed at William Blair

LVW Advisors LLC Invests $298,000 in Moderna, Inc. (NASDAQ:MRNA)

How Moderna went From pandemic hero to vaccine victim

Moderna (MRNA) Faces Multiple Regulatory Challenges

Brad Miller Joins Keystone as President of CoreAI | Morningstar

Moderna Disables Comments On X Post Announcing New Covid Shot Amid Backlash | ZeroHedge

Douglas Lane & Associates LLC Buys 99,713 Shares of Moderna, Inc. (NASDAQ:MRNA)

Moderna Shares Rise on FDA Approval of Covid-19 Vaccine | Morningstar

Greene slams FDA green lighting of Moderna's mNEXSPIKE COVID-19 vaccine | Fox News

Moderna Shares Gain On FDA Approval For New COVID-19 Vaccine

Analysts Conflicted on These Healthcare Names: CSPC Pharmaceutical Group (OtherCHJTF) and Moderna (MRNA) | Markets Insider

Moderna announces FDA approved mNEXSPIKE, new vaccine against COVID-19 | Markets Insider

CDC confirms ample supply of COVID-19 drugs, vaccines - Focus Taiwan

US FDA approves Moderna's new lower-dose Covid-19 vaccine 'mNexspike' | Health News - Business Standard

Moderna's new lower-dose COVID-19 vaccine approved by FDA

Investors Buy High Volume of Call Options on Moderna (NASDAQ:MRNA)

US approves new lower-dose COVID-19 vaccine made by Moderna

FDA Approves Moderna COVID Vaccine for Adults 65 or Older | Newsmax.com

HIV's Most Promising Breakthrough Has Taken a Hit

Moderna, Inc. (NASDAQ:MRNA) Shares Sold by California State Teachers Retirement System

FDA Covid Update: Moderna's New mNEXSPIKE Vaccine Approved for Seniors

US approves new Moderna Covid jab for over-65s

Coronavirus Vaccine: New COVID vaccine approved by US FDA: Here's all about it | - Times of India

US FDA approves Moderna's next-generation COVID vaccine for adults 65 or older

US FDA approves Moderna's next-gen COVID vaccine for adults 65 or older

Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE | Morningstar

US authorities approve Moderna's new COVID vaccine - Statement

Moderna wins narrower US approval for new COVID vaccine | Health & Fitness | ArcaMax Publishing

HHS cancels funding for Moderna vaccines to fight pandemic flu

New COVID variant NB.1.8.1: New COVID variant NB.1.8.1 spreading fast in the U.S - is your vaccine effective? Will there be a summer surge? - The Economic Times

Roivant Sciences Ltd. (NASDAQ:ROIV) Q4 2024 Earnings Call Transcript

HHS cancels Moderna's $590 million contract for bird flu vaccine | Ponca City News

Why is Trump's administration cutting bird flu vaccine funding? - CBS News

HHS axes $700M Moderna bird flu vaccine contract - is this a pivot to more dangerous, self-replicating mRNA jabs? - NaturalNews.com

Trump administration pulls bird flu, other vaccine funding awarded to Moderna

US ends $590 mn Moderna deal to develop bird flu vaccine using mRNA tech | World News - Business Standard

US cancels $766-M Moderna vaccine contract | The Manila Times

U.S. Ends $600M Moderna Bird Flu Vaccine Contract

US Cancels $700 Million Moderna Bird Flu Vaccine Contract

Trump administration cancels funding for Moderna bird flu vaccine

Trump administration yanks Moderna's bird flu vaccine research funding even as company reports promising test results - CBS Minnesota

Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2025, and Provides Business Update | Morningstar

US Cancels $590 Million Contract With Moderna for Bird Flu Shot | Newsmax.com

US cancels $590 million contract with Moderna for bird flu shot | The Manila Times

HHS terminating Moderna's $590M grant for flu vaccines | BioWorld

US cancels over $700mn funding for Moderna bird flu vaccine

US cancels US$590 million contract with Moderna for bird flu shot - CNA

Moderna, Inc. (MRNA) Reports Strong H5 Avian Flu Vaccine Data Despite HHS Funding Cut

US cancels $700m in funding for Moderna's bird flu vaccine

Trump administration cancels $766 million Moderna contract to fight pandemic flu

Moderna's $766 million pandemic flu vaccine contract canceled by Trump administration

Trump administration pulls the plug on the bird flu vaccine : NPR

HHS cuts funding to 'under-tested' mRNA technology for bird flu vaccines | Fox News

US Cancels $700M Funding for Moderna's Bird Flu Vaccine, Moderna to Explore Alternatives

Trump admin cancels $766m Moderna contract to fight pandemic flu

Trending stocks to watch: AMD, GOOG, NVDA, AMZN, MSFT

Business Trends 2025: Key Insights Shaping the Future of Global Markets

Morning Note: US Retail Dip, Moderna Struggles & Japan’s Inflation Surge

VOO etf news: The Vanguard S&P 500 ETF is down 0.13%

Week Ahead: Investors Focus on U.S. Inflation Data

Super Micro Shares Drop 8% Following Nasdaq 100 Removal

Stellar (XLM) Price Analysis: Where could XLM go in the upcoming days?

Crypto News Today: Bitcoin Price Down 1.85% as US PPI Rises

Dogecoin Price Prediction: Could Dogecoin Price Surge to $0.95?

Morning Note: Middle East Conflict Shakes Markets as Oil Soars, While AI Sector Eyes Growth

Crypto Market Sentiment: Crypto Fear and Greed Index Today

Morning Note: Adobe’s AI Momentum Leads Market Moves with Gold and Fed in Focus

BTC USD Price Prediction: How much will Bitcoin be worth in 2030?

Wells Fargo Stock Slides 1.32%: Is Wells Fargo stock a good buy now?